Emerging diagnostics and therapeutics for Alzheimer disease
WK Self, DM Holtzman - Nature medicine, 2023 - nature.com
Alzheimer disease (AD) is the most common contributor to dementia in the world, but
strategies that slow or prevent its clinical progression have largely remained elusive, until …
strategies that slow or prevent its clinical progression have largely remained elusive, until …
Emerging diagnostics and therapeutics for Alzheimer disease.
WK Self, DM Holtzman - Nature Medicine, 2023 - europepmc.org
Alzheimer disease (AD) is the most common contributor to dementia in the world, but
strategies that slow or prevent its clinical progression have largely remained elusive, until …
strategies that slow or prevent its clinical progression have largely remained elusive, until …
Emerging diagnostics and therapeutics for Alzheimer disease
WK Self, DM Holtzman - Nature medicine - pubmed.ncbi.nlm.nih.gov
Alzheimer disease (AD) is the most common contributor to dementia in the world, but
strategies that slow or prevent its clinical progression have largely remained elusive, until …
strategies that slow or prevent its clinical progression have largely remained elusive, until …
Emerging diagnostics and therapeutics for Alzheimer disease
WK Self, DM Holtzman - Nature medicine, 2023 - profiles.wustl.edu
Alzheimer disease (AD) is the most common contributor to dementia in the world, but
strategies that slow or prevent its clinical progression have largely remained elusive, until …
strategies that slow or prevent its clinical progression have largely remained elusive, until …